Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04583163 · ClinicalTrials.gov registry record
Variability in Transcranial Doppler Technique in Neuro-Critical Care Patients
A clinical trial, sponsored by Hackensack Meridian Health.
- Terminated
- Registry status
- 3
- Enrollment target
NCT04583163 is a clinical trial that was terminated before completion, run by Hackensack Meridian Health. The registered enrollment target is 3 participants.
The verdict
NCT04583163 was terminated before completion, sponsored by Hackensack Meridian Health.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
This study aims to determine the inter- and intra-variability of Transcranial Doppler (TCD) ultrasound in neuro-critical care patients who are planned for consecutive daily TCD evaluations.
Interventions
- DIAGNOSTIC_TEST Transcranial Doppler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2020-09-22 |
| Est. Completion | 2022-08-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04583163
The ClinicalTrials.gov registry entry for NCT04583163 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hackensack Meridian Health, which has 90 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcranial Doppler is the first listed.
NCT04583163 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04583163 about?
NCT04583163 is a clinical study titled "Variability in Transcranial Doppler Technique in Neuro-Critical Care Patients". This study aims to determine the inter- and intra-variability of Transcranial Doppler (TCD) ultrasound in neuro-critical care patients who are planned for consecutive daily TCD evaluations.
What is the current status of trial NCT04583163?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2020-09-22. Estimated completion is 2022-08-12.
What interventions are being tested in trial NCT04583163?
The interventions under investigation include: Transcranial Doppler (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04583163?
This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.